The U.S. death toll from the coronavirus illness COVID-19 climbed
above 177,000 on Tuesday, as experts continued to question claims made
about the use of convalescent plasma as a treatment for hospitalized
COVID-19 patients and a leading government official conceded he misspoke
at a Sunday press briefing.
Food and Drug Administration Commissioner Stephen Hahn acknowledged in a tweet posted late Monday that his comment that a study had shown plasma achieving a 35% improvement in survival was inaccurate. Hahn made the comment, accompanied by President Donald Trump, while announcing an emergency-use authorization for convalescent plasma.
Read more at:
Coronavirus update: U.S. death toll tops 177,000 as FDA head acknowledges he misspoke on convalescent plasma - MarketWatch
Food and Drug Administration Commissioner Stephen Hahn acknowledged in a tweet posted late Monday that his comment that a study had shown plasma achieving a 35% improvement in survival was inaccurate. Hahn made the comment, accompanied by President Donald Trump, while announcing an emergency-use authorization for convalescent plasma.
Read more at:
Coronavirus update: U.S. death toll tops 177,000 as FDA head acknowledges he misspoke on convalescent plasma - MarketWatch
No comments:
Post a Comment